People with sarcoidosis who respond poorly to tumor necrosis factor inhibitors (TNFi) — used to treat the immune system disease when other therapies haven’t worked — frequently develop anti-drug antibodies […] The post Monitoring for anti-drug antibodies may help improve sarcoidosis care appeared first on Sarcoidosis News.
